DENVER – Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options.
DENVER – Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over t
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular P
Comparable patterns of failure between SBRT, lobectomy or pneumonectomy for stage I non-small cell lung cancer
DENVER – For patients with medically operable clinical stage I non–small-cell lung cancer (NSCLC), lobectomy or pneumonectomy is the standard appro
DENVER – Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non–small-cell lung canc
DENVER – Recent studies have demonstrated that molecular-targeted agents, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor